Global Blood Preparation Market Outlook to 2025: Major Industry Trends, Growth Drivers and Challenges - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Mar 4, 2019--The “Global Blood Preparation Market, By Products, By Type, By Application and By Region, Market Outlook 2025” report has been added to ResearchAndMarkets.com’s offering.
The advent of automated blood component has led to the standardization of blood component preparation. It converts whole blood into different components to be used for blood transfusion and various other purposes while dramatically reducing human intervention while reducing processing time.
The report provides in-depth analysis of the current scenario, detailed market outlook of the global blood preparation market overall as well as across market segments such as products, type and application for the period 2019-25. Regional analysis is done across major markets in North America, Europe and the Asia Pacific.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market-specific growth opportunities in global blood preparation market.
Blood preparation is poised to emerge as one of the most profound sectors in the healthcare industry. The growth of the global blood preparation market is primarily attributed to rising demand for blood transfusion, the prevalence of blood disorders, increasing geriatric population, awareness of blood donation and favorable government initiatives. However, the market faces several challenges due to the high risk of disease transmission and regulatory norms.
Major industry players operating in the global blood preparation market include GlaxoSmithKline PLC, Pfizer Inc., Baxter Healthcare Corp., Bristol-Myers Squibb Co., AstraZeneca Co., among others. These players are profiled herein based on attributes such as business overview, product segments, and financial analysis. It also compiles the performance comparison of the aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section.
In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global blood preparation market.
- GlaxoSmithKline PLC
- Pfizer Inc.
- Baxter Healthcare Corp.
- Bristol-Myers Squibb Co.
- AstraZeneca Co.
1. Executive Summary
2. Research Methodology
3. Blood Preparation
3.2 Blood Components
3.2.2 Cryoprecipitated Anti-hemophilic Factor
3.2.3 Fresh Frozen Plasma
3.3 Blood Component Separation
3.3.1 PRP Method
3.3.2 Buffy Coat Method
4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Products
4.2.2 Market Share by Type
4.2.3 Market Share by Application
4.2.4 Market Share by Region
5. Market Segmentation
5.1.1 Whole Blood
5.1.2 Blood Derivatives
5.1.3 Blood Components
5.2 By Type
5.2.1 Platelet Aggregation Inhibitor
5.2.2 Fibrinolytic (Thrombolytic)
5.3 By Application
5.3.2 Angina Blood Vessel Complications
5.3.3 Pulmonary Embolism
5.3.4 Renal Impairment
6. Regional Analysis
6.1 North America
6.1.1 Market Sizing (Actual & Forecasted)
6.1.2 The US
6.2.1 Market Sizing (Actual & Forecasted)
6.2.2 Market Share by Nations
6.3 Asia Pacific
6.3.1 Market Sizing (Actual & Forecasted)
7. Market Dynamics
7.1 Industry Trends & Challenges
7.1.1 Mergers & Acquisitions
7.1.2 Automated Blood Component Preparation
7.1.3 Technological Advancement
7.2 Growth Drivers
7.2.1 Rising Demand for Blood Transfusion
7.2.2 Prevalence of Blood Disorders
7.2.3 Increasing Geriatric Population
7.2.4 Awareness of Blood Donation
7.2.5 Favorable Government Initiatives
7.3.1 High Risk of Disease Transmission
7.3.2 Regulatory Norms
8. Competitive Landscape
8.1 Market Share Analysis
8.2 Financial Analysis
9. Company Profiles
9.1 GlaxoSmithKline PLC
9.2 Pfizer Inc.
9.3 Baxter Healthcare Corp.
9.4 Bristol-Myers Squibb Co.
9.5 AstraZeneca Co.
For more information about this report visit https://www.researchandmarkets.com/research/56nhfg/global_blood?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190304005429/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Blood Banking
INDUSTRY KEYWORD: HEALTH GENERAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 03/04/2019 05:35 AM/DISC: 03/04/2019 05:35 AM